PharmGen Science, Inc. (KRX:004720)

South Korea · Delayed Price · Currency is KRW

3,030.00

+5.00 (0.17%)

Sep 14, 2026, 1:02 PM KST

Market Cap	68.40B -19.7%
Revenue (ttm)	171.66B -0.0%
Net Income	117.75M -98.2%
EPS	6.50 -98.1%
Shares Out	22.61M
PE Ratio	580.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,576
Open	3,005.00
Previous Close	3,025.00
Day's Range	2,955.00 - 3,035.00
52-Week Range	2,590.00 - 4,630.00
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About PharmGen Science

PharmGen Science, Inc. engages in the research and development, production, and sale of pharmaceutical products in South Korea. It provides prescription drugs, OTC drugs, diagnostic test kits, health and general foods, and cosmetics, as well as shampoo, conditioner, and hair oil products under the neomcell brand name. The company was formerly known as Wooridul Pharmaceutical Limited and changed its name to PharmGen Science, Inc. PharmGen Science, Inc. was founded in 1966 and is headquartered in Hwaseong-si, South Korea. [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1966

Employees 226

Stock Exchange Korea Stock Exchange

Ticker Symbol 004720

Full Company Profile

Financial Performance

In 2024, PharmGen Science's revenue was 171.29 billion, an increase of 2.70% compared to the previous year's 166.78 billion. Earnings were 2.79 billion, a decrease of -54.17%.

Financial Statements